Ghulam J Mufti - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ghulam J Mufti

Showing results (171-180 of 224) with videos related to

Pageof 23

Sort By:

American Journal of Hematology|February 15, 2016

Autoimmune diseases and myelodysplastic syndromesRami S Komrokji, Austin Kulasekararaj, Najla H Al Ali, et al.

Bone Marrow Transplantation|September 28, 2019

Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)Jesus Feliu, Victoria Potter, Francesco Grimaldi, et al.

Haematologica|March 21, 2019

Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopagBruno Fattizzo, Austin G Kulasekararaj, Anita Hill, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009

Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemiaPierre Fenaux, Ghulam J Mufti, Eva Hellström-Lindberg, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2018

Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationThomas Heinicke, Myriam Labopin, Christoph Schmid, et al.

British Journal of Haematology|September 13, 2021

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMTAvichai Shimoni, Marie Robin, Simona Iacobelli, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2012

Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.

Science Translational Medicine|February 25, 2021

Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemiaBernd B Zeisig, Tsz Kan Fung, Magdalena Zarowiecki, et al.

Blood|November 10, 2021

Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trialGuillermo Garcia-Manero, Ghulam J Mufti, Pierre Fenaux, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009

Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemiaZiyi Lim, Ronald Brand, Rodrigo Martino, et al.

Pageof 23

Search research articles

Showing results (171-180 of 224) with videos related to

Sort By:

Pageof 23

American Journal of Hematology|February 15, 2016

Autoimmune diseases and myelodysplastic syndromesRami S Komrokji, Austin Kulasekararaj, Najla H Al Ali, et al.

Bone Marrow Transplantation|September 28, 2019

Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)Jesus Feliu, Victoria Potter, Francesco Grimaldi, et al.

Haematologica|March 21, 2019

Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopagBruno Fattizzo, Austin G Kulasekararaj, Anita Hill, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2018

British Journal of Haematology|September 13, 2021

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2012

Science Translational Medicine|February 25, 2021

Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemiaBernd B Zeisig, Tsz Kan Fung, Magdalena Zarowiecki, et al.

Blood|November 10, 2021

Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trialGuillermo Garcia-Manero, Ghulam J Mufti, Pierre Fenaux, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009

Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemiaZiyi Lim, Ronald Brand, Rodrigo Martino, et al.

Pageof 23